<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00815022</url>
  </required_header>
  <id_info>
    <org_study_id>NMU-200812-MZ32</org_study_id>
    <secondary_id>NJFY0812009</secondary_id>
    <nct_id>NCT00815022</nct_id>
  </id_info>
  <brief_title>Influence of Anesthetic Temperature on Cephalad Sensory Blockade With Spinal Anesthesia</brief_title>
  <acronym>ATOCEB</acronym>
  <official_title>Influence of Anesthetic Temperature on Cephalad Sensory Blockade With Spinal Anesthesia for Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Several factors influence the extension of anesthetic mixture during spinal anesthesia
      including anesthetic gravity, body position, drug volume, and drug-delivering velocity.
      However, the effect of temperature of anesthetic mixture on the cephalad sensory blockade is
      hitherto unknown. The investigators hypothesized that different temperatures of the
      anesthetic mixture had different velocity of extension after spinal anesthesia. In addition,
      previous studies suggest that parturients have relative higher sensitivity to temperature.
      Herein the investigators proposed that the temperature of anesthetic mixture had more
      extensive effect on the cephalad sensory blockade with spinal anesthesia for cesarean
      delivery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum cephalad sensory blockade to pinprick, cold and touch</measure>
    <time_frame>From the delivery of anesthetic mixture to 15 min immediate after spinal anesthesia</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Velocity of the sensory blockade at identical body position</measure>
    <time_frame>From the delivery of anesthetic mixture to 15 min immediate after spinal anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The total dose of phenylephrine required to maintain baseline arterial blood pressure</measure>
    <time_frame>From the delivery of anesthetic mixture to 25 min after spinal anesthesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time interval of the occurrence of the hypotension</measure>
    <time_frame>From the delivery of the anesthetic mixture to 25 min after spinal anesthesia</time_frame>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">400</enrollment>
  <condition>Cesarean Delivery</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 20 degree celsius</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 10 degree celsius</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 15 degree celsius</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 25 degree celsius</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 30 degree celsius</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Mixture of anesthetic including hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg, with the temperature of 35 degree celsius</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacaine/fentanyl/morphine</intervention_name>
    <description>Hyperbaric bupivacaine 12 mg, fentanyl 10 microg and morphine 200 microg</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
    <arm_group_label>5</arm_group_label>
    <arm_group_label>6</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Nulliparous women

          2. &gt; 18 years and &lt; 45 years

        Exclusion Criteria:

          1. Allergy to opioids, a history of the use of centrally-acting drugs of any sort,
             chronic pain and psychiatric diseases records

          2. Participants younger than 18 years or older than 45 years

          3. Those who were not willing to or could not finish the whole study at any time

          4. Alcohol addictive or narcotic dependent patients

          5. Subjects with a nonvertex presentation

          6. Diagnosed diabetes mellitus and pregnancy-induced hypertension

          7. Twin gestation and breech presentation

          8. Pregnant fever
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>XiaoFeng Shen, MD</last_name>
    <role>Study Director</role>
    <affiliation>Nanjing Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nanjing Maternal and Child Health Care Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 26, 2008</study_first_submitted>
  <study_first_submitted_qc>December 26, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2008</study_first_posted>
  <last_update_submitted>January 11, 2014</last_update_submitted>
  <last_update_submitted_qc>January 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Fu Zhou Wang</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>Temperature</keyword>
  <keyword>Spinal anesthesia</keyword>
  <keyword>Cesarean section</keyword>
  <keyword>Cephalad sensory blockade</keyword>
  <keyword>Regional anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Morphine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

